Back

Sex stratified trends and segmental breakpoints in age standardized death rates for ischemic heart disease: a multi country analysis (1990 to 2021)

1 September 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Does age and sex matter for valvular disease? Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Babiker Mohamed Babiker Elsiraj

Sheikh Shakhbout Medical City SSMC, Abu Dhabi (United Arab Emirates)

7 More presentations in this session

Presentation thumbnail
TAVI in very elderly patients: long-term outcomes in a real-world cohort
Doctor N. Carrabba (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Do women fare better in tricuspid regurgitation? Unveiling the gender advantage in tricuspid valve disease
Mrs R. Hinojar Baydes (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Sex differences in pacemaker implantation, ischemic stroke, and mortality after transcatheter aortic valve implantation: a Danish nationwide study
Ms H. Vistisen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Sex-based differences after aortic valve surgery for infective endocarditis: a SWEDEHEART study
Doctor L. Bearpark (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Gender differences in clinical profiles, management, and outcomes of valvular heart disease: insights from a nationwide cohort
Ms H. Ma (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Does age and sex matter for valvular disease?

The Event

Event poster

ESC Congress 2025

1 September 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Income based disparities in ischemic heart disease mortality a global analysis of age standardized death rates (1990 to 2021)
thumbnail
Congress Presentation
Global trends in inflammatory heart disease-related mortality from 2000 to 2021
thumbnail
Congress Presentation
Global, regional and national burden of ischemic heart disease and its attributable risk factors from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources